tiprankstipranks
Advertisement
Advertisement
NanoViricides gets National Ethics Committee approval for Phase II NV-387 trial
PremiumThe FlyNanoViricides gets National Ethics Committee approval for Phase II NV-387 trial
23d ago
NanoViricides initiated with an Outperform at Noble Capital
Premium
The Fly
NanoViricides initiated with an Outperform at Noble Capital
30d ago
NanoViricides advances towards Phase II clinical trial of NV-387
Premium
The Fly
NanoViricides advances towards Phase II clinical trial of NV-387
30d ago
NanoViricides announces proposal approved by Pillar Committee in DRC
PremiumThe FlyNanoViricides announces proposal approved by Pillar Committee in DRC
2M ago
NanoViricides proposes Phase II trial of NV-387 gummies in Ebola
Premium
The Fly
NanoViricides proposes Phase II trial of NV-387 gummies in Ebola
2M ago
NanoViricides files $50M mixed securities shelf
Premium
The Fly
NanoViricides files $50M mixed securities shelf
2M ago
NanoViricides prices $2M registered direct offering
PremiumThe FlyNanoViricides prices $2M registered direct offering
3M ago
NanoViricides reports Q1 EPS (9c) vs. (14c) last year
Premium
The Fly
NanoViricides reports Q1 EPS (9c) vs. (14c) last year
3M ago
NanoViricides says hantavirus incident highlights need for antiviral drugs
Premium
The Fly
NanoViricides says hantavirus incident highlights need for antiviral drugs
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100